Low dose tolvpatan (7.5 mg) is effective in the management of SIADH in oncology patients (results from a retrospective audit at The Christie Hospital and Wythenshawe Pulmonary Oncology Unit)
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.